Literature DB >> 21681645

Emerging role of IL-23 in rheumatoid arthritis.

Feng-Lai Yuan, Xia Li, Jun-Ming Sun, Rui-Sheng Xu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21681645     DOI： 10.1007/s10067-011-1801-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy.

Authors:  Amit Kumar Singh; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2010-12-22       Impact factor: 2.980

2.  Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis.

Authors:  Tue Kruse Rasmussen; Thomas Andersen; Malene Hvid; Merete Lund Hetland; Kim Hørslev-Petersen; Kristian Stengaard-Pedersen; Christian Kanstrup Holm; Bent Deleuran
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

3.  Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes.

Authors:  K Migita; T Koga; T Torigoshi; S Motokawa; Y Maeda; Y Jiuchi; Y Izumi; T Miyashita; M Nakamura; A Komori; H Ishibashi
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

Review 4.  The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis.

Authors:  Xia Li; Feng-lai Yuan; Wei-guo Lu; Yi-qing Zhao; Cheng-wan Li; Jian-ping Li; Rui-sheng Xu
Journal:  Biochem Biophys Res Commun       Date:  2010-06-01       Impact factor: 3.575

Review 5.  IL-23 in the pathogenesis of rheumatoid arthritis.

Authors:  A Paradowska-Gorycka; A Grzybowska-Kowalczyk; E Wojtecka-Lukasik; S Maslinski
Journal:  Scand J Immunol       Date:  2010-03       Impact factor: 3.487

6.  Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis.

Authors:  Lisa K Stamp; Andrea Easson; Linda Pettersson; John Highton; Paul A Hessian
Journal:  J Rheumatol       Date:  2009-10-01       Impact factor: 4.666

7.  Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.

Authors:  Lode Melis; Bernard Vandooren; Elli Kruithof; Peggy Jacques; Martine De Vos; Herman Mielants; Gust Verbruggen; Filip De Keyser; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2009-02-05       Impact factor: 19.103

8.  IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats.

Authors:  Toru Yago; Yuki Nanke; Manabu Kawamoto; Takefumi Furuya; Tsuyoshi Kobashigawa; Naoyuki Kamatani; Shigeru Kotake
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis.

Authors:  Philippa Hillyer; Maggie J Larché; Edward P Bowman; Terrill K McClanahan; Rene de Waal Malefyt; Lauren P Schewitz; Grey Giddins; Marc Feldmann; Robert A Kastelein; Fionula M Brennan
Journal:  Rheumatology (Oxford)       Date:  2009-10-08       Impact factor: 7.580
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.